Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic combination comprising a Cdc7 inhibitor and an anti-neoplastic agent

Therapeutic combination comprising a Cdc7 inhibitor and an anti-neoplastic agent

US Patent 9119877 · Granted Sep 1, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors2015
Use of CDK inhibitor for the treatment of glioma2015
Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent2015
Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent2015
Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent2015
Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors2013
Therapeutic combination comprising a CDKS inhibitor and an antineoplastic agent2013
Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mit2011
Pyrimidylpyrrole derivatives active as kinase inhibitors2007
Pyridopyrimidinones derivatives as telomerase inhibitors2006
Distamycin derivatives, process for preparing them, and their use as antitumor a2001
Distamycin derivatives, process for preparing them, and their use as antitumor a2000